experimental neurologist and not by a phar macologist. It considers the conclusions of several recent symposia devoted to the treatment of isch emia (Barnett et aI. , 1981; Cahn , 1981; Stefanovich , 1981; Cahn , 1982; Krieglstein and Stefanovich , 1982; Janssen and Reneman , 1982) , but it does not necessarily represent the general opinion of the participants , which may deviate considerably from the viewpoints expressed in this article.
PATHOPHYSIOLOGY OF CEREBRAL ISCHEMIA
Ischemic damage inflicted upon the brain gener ally results from one or several of the following pathophysiological conditions: a gradual (athero sclerotic) narrowing or sudden (macroembolic) oc clusion of a major supplying artery of the brain , microembolism of numerous small cerebral vessels , transient global decrease or interruption of blood flow due to cardiovascular failure , or intracranial hypertension. All these conditions have in common the fact that blood flow and oxygen delivery to the brain are reduced. The pathophysiological mecha nisms of ischemic brain damage , however , differ considerably. This can be best demonstrated by comparing the following three basic types of isch emia: global (complete) ischemia , regional (incom plete) ischemia , and microembolism.
Global Ischemia
From a pharmacological standpoint , complete ce rebral ischemia of the brain is of interest only as long as it is reversible. The degree of damage re sulting from global ischemia depends on two classes of lesions , those occurring during ischemia and those occurring during the recirculation period after ischemia. At constant (normothermic) brain tem perature , ischemic changes are stereotyped. The electroencephalogram (EEG) becomes isoelectric within 15 s, primary cortical evoked potentials dis appear after 3 -5 min , and energy metabolism breaks down within 8 min (Hirsch et aI. , 1957; Lowry et aI. , 1964) . At the same time , membranes depolarize and all endergonic metabolic processes cease ( Fig. O . The depolarization of cell mem branes and the (anaerobic) generation of intracellu lar osmotically active particles cause a shift of fluid from the extracellular into the intracellular com partment , and an equilibration of transmembrane ion gradients (Hossmann , 1976) . The shifts are rapid during the initial 10-15 min of ischemia and then gradually slow down until a plateau is reached after about 30 min. There are indications that certain catabolic processes such as ribosomal disaggrega tion and protein degradation are inhibited shortly after the onset of complete ischemia (Kleihues et aI. , 1975) . Phospholipid catabolism , on the other hand , continues throughout the ischemic period , and free fatty acids accumulate linearly with the duration of ischemia (N emoto et aI. , 1980; Rehn crona et aI. , 1982) .
Changes occurring during complete ischemia can be influenced by manipulating the stores and con sumption of primary and secondary energy re serves. Hyperglycemia and various pharmacologi cal agents increase the tissue content of glucose and glycogen , and hypothermia , barbiturates , or other
Control
Ischemia Recircu lat ion metabolic inhibitors delay the consumption of these substrates during ischemia. As a result , survival time of energy-dependent processes , such as the activity of ion exchange pumps , increases and membrane polarization persists for a longer interval after the onset of ischemia (Astrup et aI. , 1977a; Siemkowicz and Hansen , 1981) . The same effect can be obtained during ischemia when some re maining blood flow is present because the continu ing supply of glucose delays the breakdown of the energy-producing metabolism (Marshall et aI. , 1975) . However , for the reasons described below , this is not necessarily associated with a better pre servation of structural integrity of the brain after ischemia.
In the earlier literature , the term "revival time" was used for the longest duration of ischemia , fol lowing which full restoration of physiological and metabolic functions of the brain was achieved (Hirsch and Schneider , 1968) . This time refers to spontaneous recovery without any treatment other than reversal of the circulatory arrest. Depending on the type of anesthesia , it varies between 8 and 12 min at normothermia. When ischemia is caused by cardiac arrest , revival time is shortened to 4-5 min because the recovery time of the heart , i.e. , the time necessary to restore cardiac function , adds to the ischemic time of the brain (Hirsch and Schneider , 1968) . These times are slightly shorter than the la tency of terminal depolarization of cortical steady potential and indicate that the brain is not irrevers- (SAP) . and the pyramidal response following electrical stimulation of the sensory motor cortex (PR). PR was evoked at times indicated by letters A-F in the polygraph (Hossmann. 1977) .
ibly damaged as long as cell membranes do not de polarize. We therefore refer to these times as "safe " revival times. After longer periods of circulatory arrest ("pro longed ischemia ") brain function and metabolism may or may not recover , depending on the envi ronmental conditions during recirculation. Without any treatment , particularly without blood pressure control, a no-reflow phenomenon develops , which after ischemia of more than 15 min may involve up to 95% of total brain volume , precluding any resto ration of metabolism or function (Ames et al. , 1968) . If a no-reflow phenomenon is avoided by reperfus ing the brain at elevated blood pressure , severe cytotoxic brain edema develops , the reason for which is a disbalance of osmotic and ionic homeo stasis between intra-and extracellular compartments (Rossmann , 1976) . During ischemia , brain tissue osmolality rises by up to 50 mOsmol and extracel lular sodium activity decreases by 60-80 mEq/L, whereas in the blood these parameters remain con stant (Fig. 2) . When the brain tissue is recirculated with blood , the resulting gradients are rapidly equilibrated by passive influx of fluid and sodium from the blood into the brain tissue , causing sudden increase of brain volume and elevation of intracra nial pressure. However , blood recirculation also supplies the brain tissue with glucose and oxygen , and energy-producing metabolism is rapidly re- (Kleihues et al. , 1974; Nordstrom et al. , 1978a) . Tissue osmolality decreases and energy dependent ion exchange pumps are reactivated , re sulting in resolution of post-ischemic brain edema (Hossmann , 1976) .
A sensitive indicator of this process is post ischemic blood flow (Fig. 3 ). During recirculation , vessels are maximally dilated because lactacidosis and extracellular hypocalcemia cause a relaxation of vascular smooth muscles. If post-ischemic brain edema is resolved quickly enough to avoid fatal in tracranial hypertension , reactive hyperemia devel ops with flow values as high as 300% of control (Zimmer et al. , 1971; . How ever , reoxygenation of brain tissue , and hence reactivation of energy metabolism , may be delayed for a variety of reasons , such as intravascular dis seminated coagulopathy , post-ischemic hypoten sion , or neurogenic respiratory insufficiency (Hossmann , 1977) . In such instances , resolution of brain edema is also delayed , intracranial pressure steadily increases , and blood flow gradually slows down. This is the reason for the fact that after pro longed ischemia , only those animals in which reac tive hyperemia is present have a chance to recover .
After an interval , the duration of which is ap proximately the same as that of the preceding isch emia , cerebral vascular tone returns and reactive 
Changes of brain water content, intracranial pressure, osmolality of brain tissue (circles) and blood (triangles), and sodium content of the subarachnoidal fluid (circles) and blood (triangles) during and after 1 h of ischemia in the cat brain (means ± SEM) (Hossmann, 1977) .
,.e. Changes of diameter of pial arteries, cortical Po2, and cortical blood flow during and after 30 min of ischemia in the cat brain (means ± SEM). Cortical blood flow was assessed by thermoclearance (Takagi et aI., 1977) .
hyperemia ceases (Takagi et aI. , 1977) (Fig. 3 ). At this time , brain edema has usually disappeared and the metabolic rate of oxygen has returned to its pre-ischemic value. In most animals , flow further decreases and stabilizes at a level slightly below control value (post-ischemic hypoperfusion) (Rossmann et aI. , 1973; Snyder et aI. , 1975; Rehn crona et aI. , 1979a ; Levy et aI. , 1979) . In con trast , post-ischemic metabolic activity may increase (post-ischemic hypermetabolism) (Rossmann et aI. , 1976; Levy and Duffy , 1977; Nemoto et aI. , 1981) ; this may result in an imbalance between oxy gen demands of the tissue and oxygen availability and hence in secondary post-ischemic relative hy poxia (Fig. 4 ). The following experiment illus trates this situation: if oxygen availability is ex pressed as mUltiples of oxygen utilization , the glucose/oxygen uptake ratio of the brain tissue increases as this value approaches unity (Fig. 5 ). This demonstrates that the brain shifts to anaerobic glycolysis as soon as oxygen availability approaches the oxygen demands of the tissue (Rossmann , 1979) . The occurrence of relative hypoxia during this period is also reflected by structural and metabolic changes in the border zones between the supplying territories of the major cerebral arteries in which flow , and hence oxygen availability , are lower than in the rest of the brain (Fig. 6) .
The obvious reason for secondary post-ischemic hypoperfusion is a disturbance of regulation of blood flow; CO2 reactivity is abolished but au toregulation is preserved (Rossmann et aI. , 1973; N emoto et aI. , 1975) . Flow , therefore , cannot be improved by either increasing blood pressure or in creasing CO2 content of the arterial blood ( Fig. 7) . Post-ischemic hypermetabolism is presumably due to partial uncoupling of oxidative metabolism , which in turn may be the consequence of a cascade of events , which recently has been discussed by Siesjo (1981) in this journal. These events may be enhanced by excessive lactacidosis (above 20-25 JLmol/g) or the availability of trace amounts of oxy gen during ischemia. Since both factors are of sig nificance during severe incomplete ischemia , this may explain the paradoxical observation that pro longed complete ischemia is better tolerated than an equally long duration of severe incomplete ischemia (Rossmann and Zimmermann , 1974; Nordstrom et aI. , 1976) . Excessive lactacidosis may also be re sponsible for the fact that ischemia in hypergly cemic animals (in which glucose stores of the brain are increased) produces more severe dam age than do hypoglycemic conditions (Myers , 1976; Siemkowicz and Ransen , 1978; Welsh et aI. , 1980) . It should be considered , however , that the de teriorating effect of hyperglycemia and incomplete ischemia becomes of significance only after the "safe" revival time has been passed , i.e. , after de polarization of cell membranes. As described above, both hyperglycemia and incomplete isch emia are associated with an extension of the safe revival time because energy-producing metabolism breaks down after a longer interval. This is the rea son for the somewhat confusing situation that the same experimental situation that facilitates re vival of the brain after short periods of ischemia worsens recovery after longer intervals.
In some animals , post-ischemic hypermetabolism or post-ischemic hypoperfusion are absent. In these Changes of metabolic rate of oxygen and glucose (CMR02, CMR-glucose), oxygen availability, and oxygen and glucose content of arterial and venous blood during and after 16 min of complete ischemia in the cat brain (means ± SEM). Note the post-ischemic increase of metabolic rate of oxygen and glucose. The early peak of glucose uptake immediately after ischemia is due to replenishment of glucose reserves and does not reflect increased glucose metabolism (Hossmann, 1979) .
cases, which presumably comprise those in which the various post-ischemic complicating side effects are minimal or absent, metabolic and functional re covery proceed astoundingly quickly even after ischemia of 1 h (Figs. 1 and 6) . Fifteen minutes after the beginning of recirculation, energy-producing metabolism recovers, cell membranes repolarize, and electrically evoked potentials reappear. After about 20-30 min, synaptical responses may be evoked, and after a few hours spontaneous EEG activity is present. At this time brain edema has been fully resolved and protein biosynthesis has been resumed, even in regions with so-called "selective" vulnerability (Hossmann and Kleihues, 1973) . Although the percentage of such experiments is relatively low (about 50% in our series of 1 h complete ischemia), they demonstrate that, in prin ciple, the brain can be resuscitated even after such a long duration of total ischemia ("theoretical " revi val time). The therapeutical implications of these findings are as follows. During ischemia, a prolongation of the latency of cell membrane depolarization would be of benefit, not, however, at the expense of in creased lactacidosis, which deteriorates resuscita tion after cell membranes have been depolarized. Following ischemia, a prerequisite for recovery is prevention of the no-reflow phenomenon. If recir culation succeeds, excess of brain edema should be prevented, and after edema has been resolved, treatment of post-ischemic hypermetabolism and post-ischemic hypoperfusion is necessary. In addi- Relationship between oxygen availability and glu cose uptake following 16 min (closed circles) and 60 min (open circles) of complete ischemia in the cat brain. The more the oxygen uptake approaches oxygen availability, the higher is the glucose/oxygen uptake ratio. This indicates stimulation of anaerobic metabolism in instances in which oxygen availability does not substantially exceed the oxygen uptake of tissue (Hossmann, 1979) .
tion , several general complicating side effects , such as post-ischemic disseminated coagulopathy or neurogenic respiratory insufficiency , have to be dealt with in order to prevent additional brain le sions. Therapy of global ischemia , in consequence , is complex sequence of procedures , which can be expected to succeed only when the pathophysiology of the process in precisely known and taken into consideration (Hossmann , 1979) .
Regional Ischemia
In contrast to global ischemia , regional obstruc tion of a major cerebral artery must not necessarily be transient in order to prevent irreversible brain damage. Localization and size of the artery , as well as the individual collateralization of the involved vessel, determine the density of ischemia and , in consequence , the degree of tissue damage (Fig. 8) . A narrowing of a supplying artery is initially com pensated for by a decrease of vascular resistance in the distant branches of this artery. Flow , there fore , does not begin to fall unless the resistance vessels in the affected territory are fully dilated. This is one of the reasons for the fact that during ischemia regulation of blood flow is abolished (Waltz, 1968; Symon et aI. , 1976) .
Starting with the work of Opitz and Schneider (1950) and elaborated in more detail by Symon and co-workers (1977) , a concept of thresholds of isch emia has been developed that relates various types of functional disturbances to well-defined levels of remammg blood flow. The most sensitive is the EEG , which begins to flatten at flow values only slightly below normal and becomes isoelectric when blood flow decreases below 15 mli100 g/min (Morawetz et aI. , 1979) . The amplitude decreases linearly with flow , indicating that with increasing density of ischemia an increasing portion of the neuropil is involved . Evoked potentials begin to decrease at flow values below 20 mV 100 g/min , and are completely sup pressed below 15 mV 100 g/min (Branston et aI. , 1977) . Cortical unit activity ceases at about 18 mVI00 g/min (Heiss et aI. , 1976) , extracellular po tassium rises below 8-10 ml/ 100 g/min (Astrup et aI. , 1977h) , and a disturbance of net water and elec trolyte content of the brain appears at flow values below 10-15 ml/ 100 g/min (Symon et aI. , 1979; Hossmann and Schuier , 1980) (Fig, 9 ). These thresholds are remarkably similar in different species and under different anesthetic drugs , indi cating that basic mechanisms are involved. It is in teresting to note that both the EEG and evoked potentials are completely suppressed at flow values that are definitely above the threshold of cell mem brane depolarization. Thus , a penumbra (Astrup et aI. , 1977h) exists between functional and structural neuronal damage , which may explain the fact that in regional ischemia , in contrast to global ischemia , functional recovery may be possible after as long as 24 h when blood flow remains above the threshold of structural integrity, Edema associated with regional ischemia is ini tially of the cytotoxic type. Similar to global isch emia , it results from an increase of tissue osmolality and a disturbance of ion homeostasis , and is as sociated with a narrowing of extracellular space . However , it already develops during ischemia because collateral blood flow provides a continuous supply of fluid and electrolytes to the ischemic tissue ( Fig. 10 ). Since ischemic brain swelling initially affects mainly perivascular glial processes , the microvasculature may be compressed and edema may further aggra vate the impact of the primary ischemia. A vaso genic type of edema , i.e. , edema associated with a leakage of serum proteins across the blood -brain barrier , develops only after several hours; at this time brain tissue presumably is already irreversibly damaged (Olsson et aI. , 1971; Kamijyo et aI. , 1977) .
The metabolic changes associated with regional ischemia have been extensively studied and do not need to be reviewed in this context. It should only FIG. 6. Regional bioluminescent evaluation of ATP concentration in intact sections of cat brain before and 3 h after 1 h of complete ischemia. Top left: control; top right: animal with unimpaired functional recovery; bottom left: animal with regional biochemical disturbances in the cortical border zones between the territories of the anterior and middle cerebral arteries (arrows); bottom right: an animal without functional and biochemical recovery (Paschen et aI., in preparation). be recalled that the relative oxygen availability of the blood (in respect to tissue oxygen demands) is much lower than that of glucose. Under physiologi cal conditions , up to 50% of oxygen but less than 10% of glucose , is extracted from the blood by the brain. A gradual decrease of flow , therefore , ini tially results in oxygen deficiency but not in glucose deficiency. For this reason , the reduced energy production by oxidative phosphorylation can ini tially be compensated for by increased glycolysis. However , since the resulting lactacidosis and other still undefined side effects will cause alterations similar to those described above for incomplete global ischemia , the efficiency of the already re duced mitochondrial respiration may further deteri orate. This is reflected by sharply demarcated re gions of very low adenosine triphosphate (A TP) content in the center of a relatively mild ischemia (Paschen et al. , 1981) , and may be the reason for the fact that different densities of ischemia produce different sizes rather than different degrees of bio chemical lesions (Fig. 11 ).
The limits of reversibility of brain damage during regional ischemia have not been clearly defined. Microelectrode recordings during and after tran sient middle cerebral artery occlusion suggest that spontaneous neuronal activity returns after an un limited period of ischemia if blood flow is kept at or only slightly below the individual functional thresh old of this cell (12-30 ml/IOO glmin). However , there was no recovery during the observation pe riod of several hours when flow decreased for only 12 min below 8 ml/IOO glmin , i.e. , a flow value that is considered to cause cell membrane depolarization Carbon dioxide reactivity and autoregulation of cerebral blood flow before and a few hours after 1 h of complete ischemia in the cat brain. Note abolishment of CO2 reactivity and preservation of autoregulation after ischemia. (Hossmann et aI., 1973) . (Traupe et aI., 1981) . This observation is at variance with earlier investigations in which recovery of spontaneous cellular activity was observed a few hours after 60 min of complete ischemia (Hoss mann, unpublished observations), and it also con-
trasts with morphological and clinical studies in monkeys and dogs after middle cerebral artery oc clusion in which infarcts could be prevented when flow was restored within 4-5 h after ischemia (Dujovny et aI., 1976; Crowell et aI., 1981) . How- , iii ever, the cessation of unit activity for hours after only 12 min of severe ischemia indicates that revival of nerve cell function requires a recovery time of considerable duration once the cell membranes have been depolarized.
The strategy for treatment of regional ischemia differs in several respects from that of global isch emia. Under most clinical conditions a reversal of the circulatory obstruction is unlikely to occur dur ing an interval that remains within the safe revival the primary interest, therefore, is to prevent the breakdown of energy-producing me tabolism and to preserve nerve-cell membrane po larization. This can be achieved either by in creasing (collateral) blood flow above the critical threshold for maintenance of ion homeostasis or by lowering the energy demands of the ischemic tissue in order to decrease this threshold. It must be con sidered, however, that the resistance vessels in the ischemic territory are fully dilated and that an im- Changes of blood flow, water, sodium, and potassium content of cerebral cortex following occlusion of the middle cerebral artery in the cat (means ± SEM). Note the development of brain edema despite continuing ischemia . provement of flow cannot be expected by a further relaxation of smooth muscle cells with vasoactive substances. Flow promotion, therefore, requires either a selective decrease of the resistance of col lateral vessels or an increase of the local perfusion pressure in the ischemic territory. Evaluation of the latter is possible by recording micropressure in dis tant branches of the occluded artery (Shapiro et aI., 1971; Matsuoka and Hossmann, 1981) (Fig. 8 ). An improvement of flow may also be possible by de creasing blood viscosity or reducing ischemic brain edema in order to relieve microcirculatory com pression by swollen astrocytic processes.
Attempts to lower metabolic activity should con sider the fact that during ischemia EEG activity is suppressed, i.e., energy cannot be saved by inhib iting functional activity (Michenfelder, 1974) . The efficiency of drugs that might be useful for improv ing flow or decreasing metabolic activity, in conse- 1982 quence, cannot be tested in normal healthy animals but must be assessed under ischemic conditions.
Microernbolisrn
The pathophysiology of microembolism differs fundamentally from that of any other form of isch emia. Microembolism is the obstruction of numer ous small arteries or arterioles by solid, viscous, or gaseous particles. Under clinical conditions, these may be platelet aggregates, fat droplets, or gas bub bles; such emboli are reversible and can be induced by intracarotid injection of arachidonate (Furlow and Bass, 1976) , adenosine diphosphate (ADP) (Fieschi et aI., 1975) , or air (Meldrum et aI., 1971) .
In animal experiments, solid microspheres have also been used, which produce a permanent occlu sion of rnicrovessels (Kogure et aI., 1973; Vise et aI., 1977) . However, this latter experimental situa-tion reflects the clinical condition to a much lesser degree.
The pathological sequel to micro embolism de pends on the size and number of emboli. When massive embolization is performed, severe ischemia or even total cerebrocirculatory arrest will ensue. However, when microembolism is less severe, the leading pathophysiological symptom is not ischemia but edema (Figs. 12 and 14) . Within less than 2 min after embolism, multiple focal disturbances of the blood-brain barrier can be detected by intravenous application of barrier tracers such as Evans blue (Schuier et al., 1978) . After 15 min, massive ex travasation is present, mainly around the cortical branches of the cerebrovascular bed. From there edema spreads into the white matter, where it ac cumulates within a few hours after embolism ( Fig. 14) .
These disturbances may appear before net blood flow of the brain decreases; since microvascular obstruction occurs at the level of arteriolar net work, occlusion of one branch is compensated for by increased flow through the unobstructed chan nels (Fig. 13) . The barrier lesions apparently are caused either (mechanically) by microembolic irri tation of the vascular endothelial cells or (hemo dynamically) by the sudden flow increase in the unobstructed arteriolar loops. As a consequence of the massive barrier lesions, brain volume and Effect of air embolism on the electroencephalogram (EEG), brain volume, intracranial pressure (ICP), and sys temic arterial pressure (SAP). Note the rapid increase in brain volume despite minor electrophysiological disturbances (Fritz and Hossmann, 1979) . cording methods is due to grossly inhomogeneous perfusion with increased flow across unobstructed vessels (Fritz and Hossmann, 1979) .
local tissue pressure increase and flow decreases until ischemia and ischemic (cytotoxic) brain edema supervenes (Vise et al., 1977) . This sequel of mild microembolism, in consequence, is opposite to that of other forms of ischemia. The primary event is vasogenic edema complicated by ischemia and cytotoxic edema, whereas in regional or complete ischemia, cytotoxic brain swelling is complicated by the vasogenic type of edema. It is obvious that this difference also requires a different therapeutical ap proach, i.e., the primary concern should be allevia tion of the breakdown of the blood -brain barrier.
Other Types of Ischemia
The pathophysiology of most other ischemic con ditions which do not fall into one of these categories can be understood by combining the relevant criteria of the here-described basic types of flow reduction. For instance, ischemia produced by in tracranial hypertension is initially an incomplete 
bottom) after embolism of the left hemisphere in cat brain with solid microspheres. Note the breakdown of the blood-brain barrier in cortical grey matter with subsequent accumulation of the tracer in the white matter (Schuier et aI., 1978) . type of ischemia, which combines the threshold characteristics of regional ischemia with the recir culation problems of global ischemia. Progressing atherosclerotic reduction of blood flow is also a threshold phenomenon similar to regional ischemia, but may include microembolic components due to aggregation of platelets. Hypotension-induced isch emia is a reversible type of incomplete ischemia, as is ischemia induced by vasospasms. The only cate gory not covered is the combination of flow reduc tion with hypoxemia or asphyxia, as exemplified by the model of anoxic-ischemic encephalopathy in troduced by Levine (1960) . Such a model, however, primarily mimicks the characteristics of anoxia, and therefore should be considered under this category of brain lesions.
CRITICAL EVALUATION OF

EXPERIMENT AL MODELS
Healthy Animals
A great number of pharmacological studies in tended to evaluate the anti-ischemic effects of drugs have been carried out in healthy animals. Drugs were applied either systemically or topically, and their influence on blood flow, metabolism, or neu rophysiological functions was measured. Therapy J Cereb Blood Flow Melabol, Vol, 2, No.3, 1982 was considered to be potentially useful for amelio ration of cerebral ischemia when the frequency of background EEG activity or amplitudes of evoked potentials increased, when the primary or second ary energy stores of brain tissue rose, when pial arteries dilated and cerebral blood flow increased, or when the mitochondrial respiratory control ratio improved. A potentially harmful effect was sug gested when the reverse occurred.
There are serious doubts that any of these param eters is of relevance for the treatment of ischemia. Activation of electrophysiological function is gen erally associated with a coupled increase of meta bolic activity (Sokoloff, 1981) ; under ischemic con ditions this may be harmful because it enhances the imbalance between oxygen supply and oxygen de mands of the tissue. Vasodilation may be of impor tance for reducing the vascular resistance of collat eral channels but is without relevance for improving flow within the ischemic territory because vessels in this area are already maximally dilated (see above). Dilation of vessels in nonischemic regions may even be harmful because this may provoke intracerebral steal effects (Toole and McGraw, 1975 ).
An improvement of mitochondrial respiratory control ratio, on the other hand, may be of thera peutical interest (Nowicki et aI., 1982) because ischemia has been shown to cause partial uncou pling of oxidative phosphorylation (Rehncrona et aI., 1979b) . Reversal of this situation, therefore, may reduce the oxygen requirements of the tissue. However, it is obvious that a basic difference exists between normal and ischemically damaged mito chondria, and one should be careful to extrapolate pharmacological effects during ischemia from those observed under physiological conditions.
In view of these considerations, the evaluation of anti-ischemic drugs in healthy animals appears to be more than problematic. It is therefore strongly rec ommended that such studies be avoided, even for screening purposes.
Survival Experiments
The effect of therapeutic procedures is frequently evaluated by measuring survival times of physio logical or metabolic functions during various anoxic or ischemic conditions. Well-known examples are the latency of the "last gasp," the survival of spontaneous EEG or evoked potentials, or the time it takes from the onset of anoxia or ischemia until energy reserves are used up. Survival times deter-mined during hypoxia or anoxia are without rele vance for ischemia and should not be considered for evaluating anti-ischemic effects. Ischemic survival, in contrast, is a reliable indicator of the relationship between energy reserves and energy consumption in brain tissue. When either parameter changes, survival times change accordingly. Therapeutic in terference, in consequence, can be easily screened by measuring these times.
However, as pointed out in the first part of this article, breakdown of energy-producing metabolism is only one among numerous factors which deter mine the outcome of an ischemic insult. If either the duration or the density of ischemia is such that de pletion of energy reserves does not occur, tissue is not irreversibly damaged. As soon as this limit has been passed, however, restoration of metabolic function may be impaired by precisely the same processes responsible for the prolongation of the survival time. Well-known examples of this situa tion are hyperglycemia or incomplete ischemia (see above). Another fact that should be considered is the necessity of pretreating the animal in order to influence ischemic survival. Even the most potent agent in this respect, hypothermia, is of little benefit when initiated after the onset of ischemia, because the energy reserves are used up so fast that the tem perature does not drop much during this interval.
The clinical relevance of therapeutic procedures that can prolong survival times is therefore limited. However, survival experiments may be of interest for screening purposes, and for as long as these pro cedures are used only for treating relatively mild or short-lasting ischemia.
Reversible Global Ischemia
Various experimental models have been de scribed for producing reversible complete or in complete global ischemia of the brain. The clinically most relevant model is induced cardiac arrest, but most laboratories prefer isolated cerebrocirculatory arrest in order to avoid interference with cardiac ischemia.
Well-known examples of isolated cerebrocir culatory arrest are strangulation by a pneumatic cuff around the animal's neck (N emoto et aI., 1977) , intracranial hypertension (Ljunggren et aI., 1974), bilateral carotid occlusion in the gerbil (Levine and Payan, 1966) , four-vessel occlusion (both carotid and both vertebral arteries) in the rat (Pulsinelli and Brierley, 1979) , isolated brain preparations (Drewes, 1980) , balloon occlusion of the aorta (Jackson and Dole, 1979) , and intrathoracic occlusion of the innominate, subclavian, and mammary arteries (Hossmann and Kleihues, 1973) . When ischemia is complete and the general physiological parameters, including body temperature, are in the normal range, highly standardized lesions are obtained, the severity of which depends only on the duration of ischemia. However, as has been described in detail in the first part of this article, there is considerable variability in the spontaneous recovery process after ischemia. Ischemic injury is also modified by any remaining blood flow, particularly during the initial phase of ischemia, because continuous influx of glucose is associated with rising lactate levels (Nordstrom and Siesjo, 1978) . For this reason, spontaneous outcome of global ischemic lesion varies considerably and statistical evaluation of therapeutic effects requires a large series of animals. The only model in which such a study is feasible is the bilateral gerbil occlusion model (Smialek et aI., 1979; Jarrott and Domer, 1980) . However, the small size of the species precludes a more detailed physiological evaluation of the re covery process.
Global cerebrocirculatory arrest in larger animals is more difficult to induce, and therefore of limited value for screening global post-ischemic recovery. It is quite useful, however, for studying therapeutic amelioration of specific post-ischemic events that have been shown to interfere with spontaneous re covery process. Examples are treatment of post ischemic brain edema, post-ischemic hypoperfusion or disturbances of flow regulation, post-ischemic hypermetabolism, disturbances of mitochondrial function, and so on. For such investigations, smaller numbers of experiments are sufficient be cause each animal serves as its own control. In terpretation of the results should consider the fact that post-ischemic recovery is a multifactorial pro cess with complex interrelations. Improving one complicating side effect, therefore, must not neces sarily improve the final clinical outcome, and ap propriate complementary experiments are neces sary to prove potential clinical usefulness.
Stroke Models
The high incidence of stroke has promoted a con siderable interest in animal models in which isch emic infarcts can be produced under controlled conditions. In rats, cats, dogs, goats, monkeys, rabbits, and other species intracerebral vessels have been occluded by clipping, ligation, or macroem bolism, and the resulting infarcts were assessed by angiography, quantitative or qualitative flow mea surements, and various functional, metabolic, and morphological methods (for review, see Rossmann, 1982) . A unique species, which differs from most other experimental animals, is the gerbil. In this species the communicating posterior arteries are missing, and unilateral occlusion of one carotid ar tery (with or without simultaneous occlusion of the opposite external carotid artery) produces infarcts in a certain percentage of experiments (Levine and Payan, 1966; Kahn, 1972) . Spontaneous infarcts occur in stroke-prone spontaneously hypertensive rats (Okamato et aI., 1974) . Most of these models have been used to test the efficiency of various therapeutic procedures, the criteria of beneficial effects being improvement of flow, reduction in the size of infarcts, amelioration of brain edema or ionic disturbances, amelioration of metabolic distur bances, improved neurological performance, or re duced mortality.
In an individual experiment, amelioration of any of these parameters can be used for assessing therapeutic efficiency. According to the concept of a threshold relationship between density of isch emia and various metabolic and functional distur bances, the other parameters can be inferred. It is not possible, however, to compare these parame ters as an endpoint in two different groups of animals without ascertaining that the primary isch emic impact was identical in the treated and un treated animals. Most authors agree that a consid erable variability in the density of ischemia exists, even when standardized surgical procedures are used and when the general physiological parameters are kept as constant as possible (Symon, 1975) . A critical factor seems to be manipulation of the ves sel during exposure because the degree of vaso spasm induced may considerably alter the efficiency of subsequent collateral blood supply (Rossmann and Schuier, 1980) . This may be one of the reasons that, in a series of experiments, infarcts tend to get smaller the more experienced the investigator be comes. By comparing untreated and treated animals, therefore, either randomization of experiments has to be performed or blood flow has to be measured before initiating therapy for appropriate matching of pairs of animals.
A special category of experiments is spontane ously occurring infarcts in hypertensive rats or in J Cereb Blood Flow Metabol, Vol, 2, No, 3, 1982 animals with induced atherosclerosis. The precise moment of occurrence of infarcts in such animals is not predictable, and the size and localization of the lesions vary even more than following any other type of vascular occlusion. Testing drug therapy in such animals, therefore, should follow the same criteria as in clinical pharmacology.
Microembolism
Two types of experimental models should be dis tinguished: irreversible embolism with solid micro spheres, and reversible embolism with gas bubbles, fat droplets, or platelet aggregates.
Embolization of the cerebrovasculature by in jecting solid microspheres (15 -50 /Lm in diameter) into the carotid artery has been proposed as a stroke model (Kogure et aI., 1973) and is used by several laboratories as a standard experimental procedure for testing drug therapy. The main advantage of this model is simplicity of surgical procedure and the reproducibility of the pathological lesion. The problem, on the other hand, is the fact that mi croembolism is not a stroke model in the clinical sense. As has been described in the first part of this article, it produces a highly inhomogeneous flow pattern with both increased and decreased flow rates at the microcirculatory level, and it causes an immediate breakdown of the blood -brain barrier to circulating macromolecules. This is in contrast to ischemic stroke, in which the blood-brain barrier breaks down after an interval of several hours (Olsson et aI., 1971) . A possible ameliorating therapeutic effect may be due to interference with either ischemia or edema formation, and therefore is difficult to interpret. Moreover, since irreversible embolism with solid microspheres is without clini cal analogy, it is not recommended for phar macological studies of anti-ischemic effects.
Reversible microembolism, in contrast, is an ap propriate experimental model of transient ischemic attacks. By intracarotid application of ADP (Fieschi et at., 1975) or arachidonate (Furlow and Bass, 1976; Passero et aI., 1981) platelet aggregation has been produced, resulting in reversible microem bolism of cerebral vasculature. A similar effect can also be obtained by injecting small gas bubbles or fat particles, which, after some time, are resolved or washed out from brain vasculature (Fritz and Rossmann, 1979; Garcia et aI., 1981) . If such mod els are used for drug therapy, randomized con trolled studies are necessary because of the great variability of pathological lesions. It should also be considered that the results are relevant only for this particular pathophysiological situation , but not for other types of ischemia.
TREATMENT OF CEREBRAL ISCHEMIA
Considering the rather strict methodological re quirements discussed above for evaluation of treatment of ischemia , the number of relevant pub lications is relatively small. It also appears that with the exception of pretreatment , few dramatic effects have been described and , if so , such effects have been questioned by other laboratories using slightly different experimental procedures. The following summary gives a survey of those therapeutic ap proaches that have been discussed most ardently during the past years.
Procedures for Improving Blood Flow and Brain Tissue Oxygenation
According to the law of Hagen and Poiseuille , blood flow can be improved by increasing blood pressure , reducing cerebrovascular resistance , or decreasing blood viscosity. All three approaches have been tested under various ischemic condi tions. Induced hypertension prevents or ameliorates the no-reflow phenomenon after prolonged isch emia and may be of benefit during later phases of post-ischemic recirculation (Cantu et aI. , 1969 ; Hossmann et aI. , 1973 ; Matakas et aI. , 1975 ; Tweed et aI. , 1977 ; Bleyaert et aI. , 1980a ) . However , there are controversial opinions about its effect in stroke. Hope et ai. (1977) reported an amelioration of neurological function by induced hypertension , but others observed no (Michenfelder and Milde , 1977) or even deteriorating effects (Fenske et aI. , 1978) , presumably because of an aggravation of vasogenic brain edema. By recording micropressure in pial branches of occluded middle cerebral artery , we observed only a slight increase of local blood perfu sion pressure during induced hypertension , indi cating that the high resistance of collateral vessels greatly reduces the transmission of a systemic pres sure pulse to the ischemic territory (Matsuoka and Hossmann , 198 1) . In spontaneously hypertensive rats , incidence of stroke is lowered by decrease of blood pressure (Yamori and Horie , 1977) .
A relief of increased cerebrovascular resistance during post-ischemic hypoperfusion has been at tempted by application of CO2 or various vaso-active drugs, such as papaverine , nitroprusside , prostacycline , nimodipine , or antiadrenergic agents (Hossmann et aI. , 1973 ; Kazda et aI. , 1976; Takagi et aI. , 1977 ; Gygax et aI. , 1978; Koch et aI. , 1979; Kazda et aI. , 1979 ;  van den Kerckhoff et aI. , in pre paration). With the possible exception of nimodi pine (Kazda et aI. , 1979) , none of these had a major effect on flow or functional recovery.
During focal ischemia , vasoactive drugs or hypercapnia did not result in a consistent improve ment either , and in some instances even provoked steal phenomena (Neumann and Benzing , 1969 ; Regli et aI. , 1971a,b; Symon et aI. , 1971; Harrington et aI. , 1972) . This is not surprising in view of the pathophysiological considerations discussed above. Welch et ai. (1972) suggested a progression of in farcts by release of serotonin from the infarcted tissue into the surrounding tissue. Pre-ischemic depletion of cerebral serotonin content by the tryptophan -hydroxylase inhibitor para-ch10ro phenylalanine decreased infarct incidence in ger bils after carotid artery occlusion , an effect that was explained by prevention of serotonin-induced vasospasms (Welch et aI. , 1977) . However , this was not confirmed in a more recent study by Harrison and Ellam (1981) .
Considerable efforts have been made to improve blood flow by reducing blood viscosity. This should, in fact , improve oxygen delivery to the brain inde pendent of vascular tone in or around the ischemic territory. Isovolemic infusion of dextran , albumin , or even saline resulted , in fact , in a significant in crease in blood circulation both in stroke models and during post-ischemic recirculation (Hossmann et aI. , 1973 ; Sundt and Waltz , 1967 ; Crowell and Olsson , 1972; Bleyaert et aI. , 1980b; Hossmann et aI. , 198 1a) . However , it did not prevent brain dam age in either situation , apparently because of the associated decrease in oxygen binding capacity. The use of low viscosity oxygen carriers such as fluoro carbone , therefore , may be of interest for improving oxygen availability. First observations, in fact , seem to indicate that this may improve post ischemic resuscitation (Mizoi et aI. , 198 1) and reduce the size of infarcts after experimental middle cerebral artery occlusion (Peerless et aI. , 198 1) .
Another approach for lowering blood viscosity without reducing oxygen binding capacity is pre vention of platelet aggregation and/or improvement of erythrocyte deformability. Platelet aggregates have been removed from the blood mechanically by fil tration with glass-wool (Hallenbeck et aI. , 1979) or pharmacologically by inhibiting prostaglandin syn thesis prior to ischemia with indomethacin (Furlow and Hallenbeck, 1978; Boulu et aI., 1981) . Addi tional substitution of prostacycline further im proved post-ischemic recirculation following global ischemia . However, there are controversial opinions about the effect of indomethacin on post-ischemic functional recovery. Gaudet and Levine (1979) reported an amelioration after 5 min of ischemia, but there was no improve ment of cortical oxygen tension or EEG activity after slightly longer lasting cerebrocirculatory arrest (Boulu et aI., 1981) . In our laboratory, prostacycline was given during post-ischemic hypoperfusion fol lowing 1 h of complete ischemia, but it did not im prove blood flow nor was there a reversal of dis turbed CO2 reactivity (van den Kerckhoff et aI., in preparation). During ischemic stroke, indometh acin deteriorated ischemic brain edema (Harris et aI., 1982) ; prostacycline did not have a signifi cant effect on either blood flow or water content (Hossmann et aI., 1981b) .
Controversial results have also been obtained with anticoagulation or fibrinolytic agents for re ducing blood viscosity. Some authors reported an amelioration of functional recovery after cardiac ar rest using heparin (Stullken and Sokoll, 1976) or streptokinase (O'Connor et aI., 1979; Lin, 1979) , whereas others did not see any beneficial effect during either stroke (Sundt and Waltz, 1967) or post-ischemic reperfusion (Bleyaert et aI., 1980a) .
Improvement of erythrocyte deformability with pentoxifyllin has been advocated by Muller and Schroer (1979) , among others, but the effect on final ischemic brain damage may be ameliorated: by cause this drug may (Bluhm and Cohen, 1978) or may not (Steen and Michenfelder, 1981) protect mitochondrial function.
In conclusion, at present, little convincing evi dence has been presented that there is any dramatic improvement of ischemic brain damage by de creasing blood viscosity alone; however, it may be used as an adjunct to other procedures, and in this respect may be of therapeutic interest.
Procedures for Influencing Metabolic Activity
There are two basically different ways by which ischemic brain damage may be ameliorated: by overall inhibition of metabolic activity in order to reduce the oxygen and substrate requirements of the brain, or by improvement of mitochondrial effi-J Cereb Blood Flow Metabol, Vol. 2, No. 3, 1982 ciency in order to optimize the energy output in the presence of reduced oxygen supply.
The most efficient procedure of metabolic inhibi tion is hypothermia. Cerebrocirculatory arrest is tolerated without neurological damage for periods of up to 30 min when temperature is lowered before ischemia to about 25°C (Lam et aI., 1950; Pontius et aI., 1954) , and up to 1 h when temperature de creases to 5-8°C (White et aI., 1973) . Further pro longation up to 1.5-2 h can be achieved when hypothermia is combined with hemodilution (Copeland et aI., 1974; Laver et aI ., 1975) or selec tive rinsing of cerebrovasculature with ice-cold Tris-saline (Bacalzo and Wolfson, 1971) . One rea son for this considerable protective effect is prolon gation of survival time of vital functions of the central nervous system, in particular delayed break down of energy-producing metabolism and mem brane depolarization (Astrup et aI., 1977a; White, 1978) . However, QlO of oxygen consumption in the brain is only 2.2 (Norwood et aI., 1979) , and since even combination of hypothermia with other pro tective procedures delays terminal depolarization to not more than 6 min (Astrup et aI., 1977a) , meta bolic inhibition cannot be the only factor involved. Cooling during regional ischemia or during the resuscitation period after ischemia is without effect or may even deteriorate ischemic brain damage (Steen et aI., 1979a; Hossmann et aI., 1981b) . This is not surprising because hypothermia lowers blood flow by increasing blood viscosity. Any reduction of oxygen requirements of the tissue, in conse quence, is annihilated by a simultaneous reduction of oxygen availability .
An alternative approach for inhibiting metabolic activity of the brain is application of various central nervous system depressant agents, such as anti epileptic drugs or anesthetics. The most widely used anesthetics are barbiturates: they have been applied both before and after the onset of regional or global ischemia (for review, see Steen and Michen felder, 1978; Safar et aI., 1978; Agnoli et aI., 1979; Astrup, 1980) . Most authors agree that bar biturates in doses between 20 and 70 mg/kg re duce the size of infarcts following middle cere bral artery occlusion, even when given up to 2 h after the onset of ischemia (Smith et aI., 1974; Moseley et aI., 1975; Hoff et aI., 1975; Corkill et aI., 1976; Levy and Brierley, 1979; Simeone et aI., 1979; Yamamoto et aI., 1979; Yonas et aI., 1979; Lawner et aI., 1979) . However, there are also some negative results, which suggest that the barbiturate effect is not as c1earcut as it might appear from these obser vations (Hayakawa and Waltz, 1975; Hossmann et aI., 1981b) . A major problem is severe interference of barbiturates with the general cardiorespiratory state (Corkill et aI., 1978; Weidler et ai., 1979; Yamamoto et aI., 1979) . In fact, in one series of experiments, barbiturates decreased the size of the infarcts but increased mortality because of cardiac insufficiency (Black et aI., 1978) .
It is interesting to note that barbiturates improve the outcome of small infarcts more than they do that of large ones. This apparently is the reason for the fact that better results were obtained in primates than in lower animal species (Michenfelder and Milde, 1975) , because the relative size of the middle cerebral artery territory decreases with increasing brain volume (Waltz, 1979) .
There are indications that the therapeutic effect of barbiturates is not solely due to metabolic inhibi tion. Other factors such as free radical scavenging (Flamm et aI., 1978) , attenuation of free fatty acid liberation (Shiu and Nemoto, 1981) , reverse steal due to vasoconstriction in the healthy hemisphere (Feustel et aI., 1981) , decrease of edema formation (Simeone et aI., 1979) , improvement of microcircu lation (Black et aI., 1979) , and decrease of intracra nial hypertension (Shapiro et aI., 1974) may also play a role.
The efficiency of barbiturates in ameliorating post-ischemic resuscitation is much more contro versial. Some authors reported a distinct improve ment of neurological and structural recovery after relatively short-lasting ischemia (Bleyaert et aI., 1978; Aldrete et aI., 1979) , but others observed no or even deteriorating effects (Steen et aI., 1979b; Pulsinelli et aI., 1979; van den Kerckhoff et aI., 1980) . This difference may be related to the density of ischemia; as reported by Nordstrom et al. (1978b) , barbiturates seem to improve recovery of severe incomplete but not of complete ischemia, which is better tolerated anyway, even without therapy.
It may be of interest to note that chlormethiazole, which in the normal brain reduces cerebral meta bolic rate of oxygen to the same degree as do bar biturates, does not have any protective effect on post-ischemic recovery (Carlsson and Rehncrona, 1979) , whereas hydroxybutyrate and hydroxy butyrolactone do (Smialek et aI., 1979) , although the latter are not anesthetic. The mechanism of barbiturate action during post-ischemic resusci tation, in consequence, is far from being solved, and any application under clinical conditions would be premature (Steen, 1980) . Antiepileptic drugs for suppressing post-ischemic hyperactivity have been used only rarely, but they seem to exert a certain ameliorating effect both after global (Cullen et aI., 1979; Siemkowicz, 1980) and regional ischemia (Bremer et aI., 1980) . A recent, promising development for therapy of both regional and global ischemia is the application of so-called anti-anoxic drugs, which improve mito chondrial efficiency. During ischemia, phospholipid degradation may lead to a disturbance of the perme ability of mitochondrial membranes. This results in disturbances of calcium equilibrium and may cause a partial uncoupling of mitochondrial oxidative phosphorylation (for a more detailed discussion of calcium-mediated cell damage, see Shay, 1973; Farber et aI., 1981; Hass, 1981; Siesjo, 1981) . There are indications that certain drugs such as midafenone, chlorpromazine, aminophylline, di hydroergotoxin, ifenprodil, nicergoline, vincamine, raubasine, and pentoxifylline are able to positively influence this process, and that this may lead to a better economization of the reduced oxygen supply (Meier-Ruge et aI., 1978; Yasuda et aI., 1978; Benzi et aI., 1979; Muller and Schroer, 1979; Tamura et aI., 1979; Delage et aI., 1981; Farber et aI., 1981; Nowicki et aI., 1982) . However, the reported de grees of therapeutic amelioration are not over whelming, and it would be of great importance to test and compare these substances under better controlled, standardized experimental conditions. This also refers to the recent report about the spec tacular ameliorating effect of the opiate antagonist naloxone, which needs further confirmation (Hoso buchi et aI., 1982) .
Treatment of Ischemic Brain Edema
An indirect approach to ameliorating tissue per fusion is treatment of ischemic brain edema. During the early phase of resuscitation after global cerebral ischemia, brain edema is the limiting factor for ade quate reperfusion of the brain (see above); reduc tion of edema by osmotherapy during this critical phase, therefore, improves or may even be a pre requisite for functional recovery (Zimmermann et aI., 1975; Lin et aI., 1979) .
During stroke, two forms of edema must be dis tinguished, the early cytotoxic type and the delayed vasogenic type (see above). The cytotoxic type of edema can be reduced in a way similar to post ischemic edema by osmotherapy using glycerol, sorbitol, mannitol, or concentrated albumin (Dod son et aI., 1975; Little and O'Shaughnessy, 1979; Bremer et aI., 1980; Rossmann et aI., 1981b; Little et aI., 1981a ) . Improvement of flow, however, is only temporary, and there is no influence on the elec trolyte shifts associated with this type of edema. Acetazolamide should not be used for preventing water uptake because this results in a distinct in crease of the size of the infarcts (Regli et aI., 1971a; Bremer et aI., 1980) . Treatment of the late vaso genic type of edema has been attempted using steroids. Some authors observed, in fact, a certain improvement of edema or blood flow (Anderson and Cranford, 1979; Fenske et aI., 1979; Bremer et aI., 1980; Hartmann et aI., 1981) , but others denied an ameliorating effect (Kahn et aI., 1972; Donley and Sundt, 1973; Lee et aI., 1974; de la Torre and Surgeon, 1976) . There is probably no influence on the infarct itself because the loss of tissue potas sium, which is a sensitive indicator of tissue necro sis, is not affected by this treatment (Fenske et aI., 1979) .
Controversial results were also reported using dimethyl sulfoxide as an anti-edematous agent after middle cerebral artery occlusion (de la Torre and Surgeon, 1976; Little et aI., 1981b) . Edema as sociated with microembolism improved with glycerol (Popovic et aI., 1978) but not with steroids (Siegel et aI., 1972) .
Looking at these results, it is difficult to extract a general therapeutic pattern even when the different pathophysiological properties of the animal models used are considered. One, therefore, is tempted to conclude that, with the exception of post-ischemic recirculation edema, treatment of ischemic brain swelling does not substantially improve the final outcome of an ischemic insult.
CONCLUSIONS AND RECOMMENDATIONS
FOR FUTURE STUDIES
The different pathophysiology of various types of ischemia makes it impossible to define any therapeutic procedure as "anti-ischemic" in a gen eral sense. Even opposite effects may be obtained by the same approach under different pathophysi ological conditions. An example is induced hyper tension, which may prevent or reverse the no reflow phenomenon during the initial recirculation phase after ischemia but which will promote edema formation at a later stage. For this reason, two things must be clearly defined before testing any J Cereb Blood Flow Metabol, Vol. 2, No . 3, 1982 anti-ischemic procedure : the pathophysiological situation which this procedure intends to improve and the experimental model in which this situation can be produced under controlled conditions. The evaluation of a therapeutic effect must follow standard pharmacological and statistical criteria , but this should not present a major problem.
In conclusion of the above-discussed con sid erations, the following models might be of interest for investigating new therapeutic procedures.
Global Ischemia-Resuscitation After
Cerebrocirculatory Arrest
For screening purposes, bilateral artery occlusion in the gerbil or four-vessel occlusion in the rat may be used. Criteria of a beneficial effect can be sur vival after recirculation or absence of histological changes. For a detailed study of therapeutic amelio ration of post-ischemic resuscitation, well-defined, post-ischemic, complicating side effects such as no-reflow phenomenon, post-ischemic brain edema, post-ischemic hypoperfusion, post-ischemic hyper metabolism, disturbances of mitochondrial func tion, etc., can be investigated in any animal model in which a standardized reversible type of global ischemia can be produced.
Chronic Cerebrovascular Insufficiency
From a clinical standpoint, this type of mild global ischemia is probably the most important therapeutic problem because even minor changes of blood flow and metabolism may produce a consid erable improvement of neurological state when flow is near the threshold of functional disturbance. Unfortunately, only a few experimental models are available in which this situation can be studied. The clinically most relevant model presumably is the spontaneously hypertensive rat, in which a gradual narrowing of the vascular bed occurs. Possibly, the same effect may be obtained by a gradual occlusion of the carotid arteries in gerbils or rats (after previ ous ligation of vertebral arteries), using occlusors or locally induced atherosclerotic plaques. Criteria of anti-ischemic effects in such animals could be sur vival rate, histological changes, or changes of threshold relationship between blood flow, metabo lism, and functional activity. The latter can be as sessed in small animals using recently developed, regional multiparametric techniques.
Regional Ischemia
For screening purposes, the most convenient technique for production of ischemic infarcts is unilateral carotid artery occlusion in gerbils (with or without additional ligation of the contralateral ex ternal carotid artery). Criteria of drug efficiency could be the same as suggested for assessing chronic cerebrovascular insufficiency. For more detailed pathophysiological investigations, well established surgical procedures such as transorbital occlusion of the middle cerebral artery are avail able, which can be applied to different animal species including primates. In such experiments, evaluation of drug efficiency should be performed by appropriate matching of treated and untreated animals with comparable ischemic impact after vascular occlusion. The most convincing criterion of a positive effect is absence of histological lesions , but other parameters described in this review may also be used.
Microembolism
The use of this experimental model for the study of anti-ischemic effects is limited and should be re stricted to evaluation of therapeutic procedures in tended to ameliorate the effects of reversible mi crovascular occlusion. Arachidonate-or ADP induced platelet aggregates or small air bubbles may be used for this purpose. Microembolism with solid particles is not recommended because the patho physiology of this lesion is complex and not repre sentative of most of the clinically relevant ischemic conditions.
Other models that are not recommended for the study of anti-ischemic effects include healthy ani mals and any type of asphyxia, hypoxic or anoxic hypoxemia, anemia or toxic hypoxidoses. In these experimental situations, reduction of blood flow, as a main denominator of ischemia, is absent. Instead, the use of established, pathophysiologically well characterized, experimental models of cerebral ischemia should provide the greatest chance for progress in a field of therapy that has been so re markably unsuccessful in the past. 
